Search Results - "Hujer, Kristine"
-
1
The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond
Published in Clinical infectious diseases (14-06-2024)Get full text
Journal Article -
2
Global challenge of multidrug-resistant Acinetobacter baumannii
Published in Antimicrobial agents and chemotherapy (01-10-2007)Get full text
Journal Article -
3
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
Published in Antimicrobial agents and chemotherapy (01-04-2017)“…Based upon knowledge of the hydrolytic profile of major β-lactamases found in Gram-negative bacteria, we tested the efficacy of the combination of…”
Get full text
Journal Article -
4
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
Published in Clinical infectious diseases (15-03-2017)“…Background. Polymyxins including colistin are an important "last-line" treatment for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKp)…”
Get full text
Journal Article -
5
ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases
Published in Antimicrobial agents and chemotherapy (01-01-2019)“…The activity of the siderophore cephalosporin cefiderocol is targeted against carbapenem-resistant Gram-negative bacteria. In this study, the activity of…”
Get full text
Journal Article -
6
NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas
Published in Antimicrobial agents and chemotherapy (01-07-2017)“…Among Gram-negative bacteria, carbapenem-resistant infections pose a serious and life-threatening challenge. Here, the CRACKLE network reports a sentinel…”
Get full text
Journal Article -
7
Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa
Published in Antimicrobial agents and chemotherapy (01-02-2015)“…Pseudomonas aeruginosa is a notoriously difficult-to-treat pathogen that is a common cause of severe nosocomial infections. Investigating a collection of…”
Get full text
Journal Article -
8
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Published in Journal of Bacteriology (01-12-2008)“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
9
An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the “Perfect Storm”
Published in The Journal of infectious diseases (01-01-2018)“…Abstract Background Carbapenem resistance is a critical healthcare challenge worldwide. Particularly concerning is the widespread dissemination of Klebsiella…”
Get full text
Journal Article -
10
Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
Published in The Journal of infectious diseases (15-08-2017)“…Background. Extremely drug-resistant (XDR) Acinetobacter baumannii is one of the most commonly encountered, highly resistant pathogens requiring novel…”
Get full text
Journal Article -
11
A γ-Lactam Siderophore Antibiotic Effective Against Multidrug-Resistant Gram-Negative Bacilli
Published in Journal of medicinal chemistry (11-06-2020)“…Treatment of multidrug resistant Gram-negative (Gr-) bacterial pathogens represent a critical clinical need. Here we report on a novel γ -lactam pyrazolidinone…”
Get full text
Journal Article -
12
New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis
Published in mBio (21-01-2014)“…Acinetobacter baumannii is a globally important nosocomial pathogen characterized by an increasing incidence of multidrug resistance. Routes of dissemination…”
Get full text
Journal Article -
13
A molecular analysis of meropenem-vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae
Published in Antimicrobial agents and chemotherapy (08-10-2024)“…We characterized the molecular determinants of meropenem-vaborbactam (MV) non-susceptibility among non-metallo-β-lactamase-producing KPC- (KPC- ). Whole-genome…”
Get more information
Journal Article -
14
In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
Published in Antimicrobial Agents and Chemotherapy (01-01-2010)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
15
Host Fate is Rapidly Determined by Innate Effector-Microbial Interactions During Acinetobacter baumannii Bacteremia
Published in The Journal of infectious diseases (15-04-2015)“…Background. Acinetobacter baumannii is one of the most antibiotic-resistant pathogens. Defining mechanisms driving pathogenesis is critical to enable new…”
Get full text
Journal Article -
16
Staphylococcus aureus and Acinetobacter baumannii Inhibit Osseointegration of Orthopedic Implants
Published in Infection and immunity (17-03-2022)“…Bacterial infections routinely cause inflammation and thereby impair osseointegration of orthopedic implants. Acinetobacter spp., which cause osteomyelitis…”
Get full text
Journal Article -
17
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV
Published in Clinical infectious diseases (17-05-2019)“…Abstract Background Overcoming β-lactam resistance in pathogens such as Pseudomonas aeruginosa is a major clinical challenge. Rapid molecular diagnostics…”
Get full text
Journal Article -
18
Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam
Published in mBio (19-12-2023)“…Multi-drug resistant (MDR) harbor a complex array of β-lactamases and non-enzymatic resistance mechanisms. In this study, the activity of a…”
Get full text
Journal Article -
19
Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
Published in mBio (12-03-2019)“…Multidrug-resistant (MDR) spp. poses a significant therapeutic challenge in part due to the presence of chromosomally encoded β-lactamases, including class C…”
Get full text
Journal Article -
20
Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
Published in Antimicrobial Agents and Chemotherapy (01-12-2006)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article